Defective Drug Attorneys in New York City
Assisting Those Harmed by Dangerous Drugs
Those who have been harmed by a defective drug or an improperly filled prescription are encouraged to enlist the services of our defective drug attorneys in Manhattan, New York. At Proner & Proner, serving clients from throughout New York and the entire nation, our defective drug attorneys represent victims in lawsuits against negligent drug makers. We can’t take back the pain and suffering that result from the use of a defective drug and other defective products, but we can fight on your behalf for the compensation that is rightfully yours.
About Defective Drugs and Improperly Filled Prescriptions
The pharmaceutical industry spends billions of dollars every year to develop and market prescription and over-the-counter (OTC) drugs. These drugs are intended to combat a range of ailments, including cancer, allergies, and arthritis. Unfortunately, drug manufacturers sometimes fail to disclose all information about the adverse effects a drug can have, leaving physicians and consumers unaware of the potential reactions that can occur.
People are also sometimes harmed when their pharmacists improperly fill their prescriptions by either dispensing incorrect dosages, or even worse, the wrong prescription entirely.
Prescription Negligence Facts
The statistics on prescription negligence are frightening. According to the Journal of the American Medical Association, errors in filling prescriptions result in more than 550,000 injuries and more than 100,000 deaths each year. Out of the 3 billion prescriptions filled annually, an estimated 51.5 million errors are made, and 3.3 million of these are potentially dangerous mistakes.
When a patient is given a medication that conflicts with a drug the patient is already taking, major injury or death can occur. In this case, you may have a lawsuit against your pharmacists and/or physicians and should consult one of our defective drug attorneys.
People can be permanently injured or even killed by defective drugs. Likewise, improperly filled prescriptions kill thousands each year and injure more than half a million. The defective drug attorneys of Proner & Proner in New York are experienced in filing lawsuits against negligent physicians and doctors and the makers of defective drugs. If you or a loved one has been injured due to drug-related negligence, contact our defective drug attorneys in Manhattan today.
Defective Drug Litigation – List of Dangerous Drugs
Below is a list of various defective drugs and pharmaceuticals that have caused serious injuries and health problems. If you or someone you love has been harmed as a result of these defective or dangerous drugs, we encourage you to contact our defective drug attorneys in New York. We represent clients all over the country and refuse to be intimidated by large drug companies or manufacturers.
Arava®, also known as Leflunomide, is a drug used to treat active rheumatoid arthritis. The drug was approved in 1998, when the FDA noted that Arava® worked just as well as methotrexate – an older drug already being used to treat rheumatoid arthritis – and thought that consumers could use some different options.
Unfortunately, Arava® can cause serious side effects, most notably severe liver damage. On March 29, 2002, the consumer group Public Citizen requested that the FDA ban Arava® due to its possible health risks. There have been 130 reports of serious liver damage among Arava® patients, 56 hospitalizations, and 12 deaths. In addition to liver damage, Arava® can also increase blood pressure, increase a patient’s risk of stroke, and cause serious gastrointestinal, skin, and blood reactions. It’s also been linked to Steven-Johnson Syndrome, a severe autoimmune disease.
Aventis, the manufacturer of Arava®, is considering strengthening the drug’s warning labels, but Public Citizen has asked the FDA to withdraw it. So far, the FDA has done nothing to respond to the side effects caused by Arava®. About 1.5 million prescriptions for Arava® have been written in the United States since the drug was introduced.
If you are taking Arava® and have elevated liver enzymes or symptoms of Stevens-Johnson Syndrome such as headache, fever, and lesions, consult a physician. If you or a loved one has taken Arava® and suffered side effects, contact the New York City defective drug lawyers at Proner & Proner today.
Baycol® was approved for use in 1997 to lower cholesterol and reduce the risk of heart attacks. It belongs to a class of cholesterol drugs known as statins. All statin drugs are known to increase a person’s risk of developing damage to muscle and the rare muscle condition known as rhabdomyolysis. Rhabdomyolysis can be fatal, and Baycol® was found to increase the risk of this condition more than other statin drugs. The dangerous side effects were particularly pronounced in patients taking high doses of Baycol®. In all, Baycol® has been linked to more than 100 deaths.
On August 8, 2001, Baycol® was voluntarily recalled by its manufacturer, Bayer A.G. Pharmaceuticals. The recall was done in light of 52 Baycol® deaths and 416 cases of rhabdomyolysis; later it became clear the death toll was higher, around 100 people.
Bayer refused to acknowledge that Baycol® was dangerous, however. Bayer simply adjusted the recommended dose of Baycol®, alleging that patients weren’t taking Baycol® in correct dosages.
In addition, court evidence has shown that Bayer deliberately avoided studying rhabdomyolysis-related side effects caused by Baycol®. To date, in New York City and across the nation, about 3,000 Baycol® defective drug lawsuits have been settled.
If you or a loved one has suffered serious side effects after taking Baycol®, contact our New York City defective drug attorneys.
Celebrex® was a heavily advertised prescription arthritis drug that, along with its competitor Vioxx®, became a blockbuster drug soon after its introduction.
Celebrex® is a painkiller for arthritis patients that works by blocking a protein called COX-2 that has been connected with inflammation. After it went on the market in 1999, more than 27 million Americans were prescribed Celebrex®.
When a fellow COX-2 inhibitor, Vioxx®, was pulled off the market in light of its dangers to patients, Celebrex® was scrutinized and found to be similarly dangerous.
Though it was intended to be easier on the stomach than other arthritis drugs, at least 10 people have died of stomach complications while taking the drug and at least 11 others have been hospitalized due to gastrointestinal bleeding. The drug has also been linked to an increase in the risk of heart attacks, strokes, blood clots, liver damage, kidney failure, high blood pressure, and sudden death. In December 2004, a government-sponsored Celebrex® trial was halted after those taking the medicine had more than twice as many heart attacks as those taking a placebo.
In February 2000, the FDA denied the request of Pharmacia and Pfizer, manufacturers of Celebrex®, to remove warning labels about the risk of serious stomach problems among Celebrex® patients. In some cases it’s been found that the manufacturer of Celebrex® failed to disclose all of its research data which hinted at the drug’s dangers. Patient safety might have been compromised in the midst of the tight competition between Celebrex® and its rival, Vioxx®.
If you or a loved one has been injured by Celebrex®, you should seek legal representation. Contact the New York City-based defective drug attorneys at Proner & Proner today.
Fen-phen, also marketed as Redux and Pondimin, was a popular diet drug in the 1990s until its 1997 recall.
Fen-phen is a combination of either fenfluramine or dexfenfluramine and phentermine. Fen-phen was recalled after both fenfluramine and dexfenfluramine were associated with heart valve damage and primary pulmonary hypertension (PPH). PPH is a condition characterized by the progressive narrowing of the blood vessels in the lungs, leading to abnormally high blood pressure and, sometimes, heart failure. Studies show that taking Fen-phen can increase your chances of developing PPH by as much as 30 percent. There is no known cure for PPH, which can lead to symptoms like shortness of breath, chest pain, bluish lips and skin, and fainting. PPH can be fatal if not treated.
Fen-phen is also associated with problems in the heart valves. The aortic and mitral valves of the heart can be impaired, causing blood to be regurgitated back into the ventricle and left atrium. Heart valve disease such as this can be subtle – shortness of breath and chest pain – and can be treated, but requires long term monitoring and medication.
By the time fen-phen was pulled off the market, it’s estimated that 6 to 7 million Americans had taken the drug. Anyone who has taken fen-phen should visit a doctor and obtain a physical examination, echocardiogram, and a complete medical history. Those who took fen-phen may just now experience medical conditions associated with the drug.
If you or a loved one has taken fen-phen, seek medical attention and contact Proner & Proner to speak with one of our New York City defective drug lawyers.
Lotronex® is a prescription medication used to treat irritable bowel syndrome (IBS) in women. It was recalled only nine months after being released in 2000 after it was linked to ischemic colitis, severe constipation that caused severely obstructed or ruptured bowels, and death. However, the drug was reintroduced on a limited basis in 2002 under certain guidelines; it is only to be used to treat diarrhea-predominant irritable bowel syndrome in women and prescribed by doctors with specific qualifications.
Ischemic colitis can cause intestinal damage as a result of reduced blood flow to the intestine and, in severe cases, death. Before its recall, Lotronex® was also found to cause severe constipation in some women, requiring hospitalization in most cases and surgery in some. In total, eight deaths and 124 hospitalizations were reported to the FDA at the time of the Lotronex® recall. Four cases of ischemic colitis occurred during the drug’s clinical trials.
Glaxo Wellcome, Inc., manufacturer of Lotronex®, voluntarily recalled Lotronex® at the FDA’s request but did not agree that the drug was dangerous. Now that the drug is back on the market for limited prescription, more reports of severe or deadly side effects may come out.
At Proner & Proner in New York City, we are currently handling defective drug lawsuits involving the prescription drug Lotronex®. If you or a loved one has taken Lotronex® for irritable bowel syndrome and suffered severe constipation or ischemic colitis, contact our defective drug attorneys today.
Meridia® is a prescription diet drug that has been used by many Americans to medically treat obesity by affecting the appetite control centers in the brain. The safety of Meridia®, however, has been brought into question ever since it went on the market in 1998.
Thirty-two deaths and 400 cases of serious adverse reactions have occurred among American Meridia® patients. Most of the deaths were due to cardiac problems. In addition, at least 143 Meridia® patients have developed heart arrhythmia. The drug has been linked to high blood pressure, inability of blood to clot, seizures, neurological disorders, and heart failure.
Since 2002, consumer advocacy group Public Citizen has been pushing the FDA to recall Meridia®, but the FDA has rejected its appeals. An FDA advisory committee didn’t believe that the benefits of Meridia® outweighed its risks, and the FDA has demanded that Meridia® manufacturer Abbott Laboratories change advertising and promotional materials that exaggerated the effectiveness of Meridia®.
Worldwide, 8.5 million people have taken the drug. Meridia® has already been recalled in Italy, where two people have died and many others have reported serious side effects. If you or a loved one has been hurt by Meridia®, contact our experienced New York City defective drug lawyers to learn about your legal options.
OxyContin® is a prescription medication used to relieve the pain associated with serious injuries, cancer, arthritis, and other severe and chronic pain. An opium alkaloid, OxyContin® can be highly addictive and can produce feelings of euphoria along with pain relief. For this reason, many people abuse OxyContin®, subverting its time-release formula by crushing or dissolving the pill. OxyContin® can have deadly effects, as an overdose causes the patient to stop breathing.
According to the Drug Enforcement Agency, at least 300 people have died from OxyContin® abuse in the past two years. In light of these deaths, the FDA added a “black box” warning to OxyContin® labels in 2001, and the makers of OxyContin® issued a “Dear Healthcare Professional” letter to physicians, pharmacists, and other healthcare professionals warning them of the problems associated with the abuse of OxyContin®.
It’s alleged that Purdue Pharma, manufacturers of OxyContin®, failed to tell patients and doctors about the drug’s powerfully addictive effects during their aggressive marketing campaign aimed at doctors. To date, about 1,000 OxyContin® defective drug lawsuits have been filed against the drug’s makers.
The prevalence of opiate painkillers such as OxyContin® has dramatically risen in the past few years, making it a high-priority drug problem in America. If you or a loved one has suffered the addictive or deadly effects of OxyContin®, speak to our New York City defective drug attorneys right away.
Paxil® is a prescription drug used to treat depression, anxiety, and obsessive-compulsive disorder. It is a selective serotonin reuptake inhibitor (SSRI), and works by regulating levels of the serotonin in the brain, the chemical responsible for feelings of calm and happiness.
In summer 2003, the British equivalent of the FDA found that Paxil® was linked with a threefold increase in suicide among children taking it. They recommended that Paxil® not be prescribed to children, because the risk of suicide outweighed the drug’s benefits. In 2004, the FDA mandated that GlaxoSmithKline put warning labels on Paxil®.
More information about the link between Paxil® and suicidal thoughts continues to surface. On May 12, 2006, GlaxoSmithKline sent a warning letter to doctors nationwide, warning them of this suicide risk among young adults taking the drug.
Paxil® can also cause dependence and severe withdrawal symptoms, including nausea, depression, homicidal or suicidal feelings, anxiety, and sensory distortions. In many cases, the withdrawal symptoms are significantly worse than the original problem being treated with Paxil®. In December 2001, the FDA decided to add a warning to the Paxil® label about the risk of severe withdrawal symptoms in patients who stop taking Paxil®.
If you or a loved one has suffered injuries while taking Paxil®, Proner & Proner in New York City can help.Contact one of our qualified defective drug attorneys to protect your legal rights.
Phenylpropanolamine, or PPA, is an ingredient commonly used in many over-the-counter nasal decongestants, cough and cold medications, appetite suppressants, and diet pills. PPA’s safety was brought into question by researchers at the Yale University School of Medicine, who found that PPA increases the risk of hemorrhagic strokes in women, especially younger women.
As a result, the FDA asked manufacturers to remove PPA from their products in November 2000. However, since PPA is an over-the-counter drug, the FDA cannot ban PPA, and the ingredient continues to be used in many cold medicines, nasal decongestants, and diet pills. It’s estimated that 200 – 500 people, mostly women under 50, have suffered hemorrhagic strokes after taking medications containing PPA. Hemorrhagic strokes can be deadly; they occur when the brain or tissue surrounding the brain bleeds. PPA can cause hemorrhagic strokes without warning, and they can have irreversible effects.
More than two dozen defective drug lawsuits have been filed challenging PPA’s safety, but these have been quietly settled by teams of defective drug lawyers representing the drug’s manufacturers. These quiet settlements have kept the public largely ignorant of PPA’s potential danger.
An estimated 6 billion doses of medications containing PPA are sold each year. If you have taken a medicine containing PPA and suffered a hemorrhagic stroke, contact our skilled team of New York City defective drug lawyers today.
Prempro™ is a hormone replacement therapy (HRT) drug that combines estrogen and progestin and was used to treat the symptoms of menopause, such as mood swings, hot flashes, night sweats, vaginal dryness, and osteoporosis. It was the leading Hormone Replacement Therapy (HRT) drug, prescribed to 6 million women nationwide.
A study of 16,000 women taking Prempro™ was abruptly ended by the National Institute of Health when disturbing preliminary findings surfaced. It was found that women using the drug for as little as a year were subject to increased risk of heart disease, stroke, breast cancer, and blood clots. More recent studies even link Prempro™ and other HRT drugs to higher risks of stroke and dementia.
However, despite all these risks, hormone replacement drugs have not been taken off the market and Wyeth, the maker of Prempro™, has no plans to recall the drug. Wyeth, however, cut the recommended dosage of Prempro™ by half, and recommended against long-term use. Long-term use of estrogen was found to increase the risk of ovarian cancer by 220 percent.
If you or a loved one has experienced blood clots, breast cancer, or another side effect while taking the drug, contact our New York City defective drug attorneys right away to discuss recent Prempro™ lawsuits.
Rezulin® was a drug used to regulate insulin and blood sugar levels in patients with type II diabetes. It was approved by the FDA in 1997 after only six months of trials and was recalled on March 21, 2000 after being linked to 63 deaths, 90 cases of life-threatening liver damage, and heart failure. It was concluded that those taking Rezulin® were 1,200 times more likely to suffer liver damage than a control group.
Rezulin® was recalled soon after two new diabetes drugs, Avandia® and Actos®, became available, each of which was much safer than and just as effective as Rezulin®. Parke-Davis/Warner-Lambert, manufacturer of Rezulin®, complied with the FDA’s request to remove Rezulin® from the market.
Warner-Lambert was accused of knowing as early as 1993 of at least one patient who displayed signs of liver damage after taking Rezulin®. The Los Angeles Times reported that Warner-Lambert downplayed the potential for liver damage when seeking federal approval of Rezulin®.
Symptoms of liver disease include abdominal pain, breast enlargement in men, coughing up or vomiting large amounts of blood, curling of the fingers, dark urine, fatigue, fever, hair loss, yellowing of the skin and eyes, muscle wasting, nausea, and poor appetite. If you or a loved one has experienced any of these symptoms or has otherwise been injured by Rezulin®, contact the defective drug lawyers at Proner & Proner today.
Serzone®, known generically as nefazodone, was a controversial antidepressant linked to potentially fatal liver complications first put on the market in 1994.
In December 2001, the FDA added a “black box” warning to the Serzone® label, after news surfaced that the drug was linked to 55 cases of liver failure and 20 deaths. In addition to its risks of irreversible liver failure, Serzone® is potentially linked to increased suicide risk when taken by children, as well as seizures, mania, low blood pressure, fainting, and other side effects.
In 2004, Bristol-Myers Squibb announced it would stop manufacture and sales of Serzone®. The drug had already been withdrawn in Canada, Europe, Australia, and New Zealand, and Bristol-Myers Squibb acknowledged the Canadian withdrawal was because of the drug’s risks of liver damage. However, they insisted the American discontinuation was because of poor sales, not because of its side effects.
Before its discontinuation, Serzone® was not shown to work any better than other antidepressants in its class. In a study of Serzone® conducted prior to its marketing, 16 percent of the 3,496 patients taking Serzone® quit taking it due to side effects.
Serzone® is just one antidepressant of many that can cause deadly side effects. If you or a loved one has been injured by Serzone®, don’t delay in contacting the New York City defective drug lawyers of Proner & Proner.
Thimerosal is a mercury-containing preservative that has been used in vaccines since the 1930s. In 1997, the FDA recommended a gradual removal of thimerosal from vaccines because of concerns over its mercury content, and in 1999 thimerosal began to be eliminated from vaccines.
In high enough doses, mercury can cause neurological and other disorders, especially in children. Some have speculated that vaccines preserved with thimerosal may contribute to the development of autism and other neurodevelopmental disorders, such as ADHD and speech disorders, in children. Although a definitive link between thimerosal and autism has proven elusive, some parents of autistic children feel that there is a distinct connection between the time of their child’s vaccinations and the appearance of autistic symptoms.
Cases of autism have skyrocketed, to 1 in 250 children – up from just 1 in 10,000 children before 1980. Critics have pointed out that children now regularly receive 30 vaccines, an increase from pre-1980 levels. Autism is a neurological disorder marked by sensory, neurological, motor, and behavioral problems. It generally appears within the first two years of a child’s life.
If your child has received vaccines containing thimerosal and has developed autism, you may be able to pursue a case. Contact our New York City legal team today; our defective drug attorneys can give you the representation you need to win thimerosal lawsuits.
When Vioxx® was first released in 1999, arthritis sufferers hailed the anti-inflammatory non-steroidal medication as a miracle as it proved to be highly effective in managing acute pain.
A clinical trial was initiated in the year 2000 to study the drug’s ability to prevent recurring polyps in the colon. While Vioxx® successfully prevented the formation of new polyps, a significant number of study subjects developed cardiovascular problems 18 months after the study was completed. Twice as many Vioxx® recipients suffered heart attacks, strokes, or blood clots as study subjects who received placebos. Since then, Vioxx® has also been linked to other life-threatening side effects such as meningitis, severe intestinal damage, ulcerations, bleeding, and kidney damage.
While the manufacturer of Vioxx®, Merck & Co., claims that long-term use of Vioxx® poses a relatively low risk of heart attacks and other serious side effects, the company voluntarily halted the clinical trial and removed Vioxx® from all pharmacies on September 30, 2004. With an estimated 80 million Vioxx® users worldwide, the recall of Vioxx® is considered one of the largest drug recalls in history.
Merck & Co.’s decision to remove Vioxx® from pharmacies is a relief to patients and consumers, but for those who have used Vioxx® since its initial release, the actions of Merck & Co. came too late. If you or someone you love has been harmed by or suffered from a serious cardiovascular problem as a result of taking Vioxx®, contact the New York City defective drug lawyers of Proner & Proner immediately for a consultation.
Other Drugs and Drugmakers:
Zimmer Nexgen Products
Contact Our Defective Drug Attorneys
Our defective drug attorneys of Proner & Proner have extensive experience handling lawsuits for victims injured by defective prescription medications and over-the-counter drugs. If you have been injured or a loved one has died as a result of taking a defective drug, please contact our defective drug attorneys in New York City.